Olanzapine is an atypical antipsychotic medication primarily used to treat schizophrenia and bipolar disorder. It functions by modulating various neurotransmitter systems in the brain, particularly dopamine and serotonin receptors, which helps alleviate symptoms of these mental health conditions. The chemical formula of olanzapine is C17H20N4S, and it features a thienobenzodiazepine structure, which contributes to its pharmacological properties. Olanzapine is typically administered orally and is available in various formulations, including tablets and orally disintegrating tablets. Its pharmacokinetics indicate a relatively long half-life, allowing for once-daily dosing in many cases. Common side effects may include weight gain, sedation, and metabolic changes, necessitating monitoring during treatment. Due to its efficacy and side effect profile, olanzapine has become a widely prescribed medication in psychiatric practice. As with all medications, it is essential for patients to discuss potential benefits and risks with their healthcare provider.

Olanzapine

132539-06-1: 2-Methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine, 10H-Thieno[2,3-b][1,5]benzodiazepine, 2-methyl-4-(4-methyl-1-piperazinyl)-, Olanzapine, LY 170053, Zyprexa

Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoi

CAS 132539-06-1: Olanzapine

Olanzapine

Ref: 45-1478301

Olanzapine

Ref: TR-LPM-OLZ-1064-FB

Olanzapine, USP grade

Ref: 7W-GP8012

Olanzapine

Ref: 47-1060

Olanzapine 1.0 mg/ml in Acetonitrile

Ref: TR-LGCAMP0329.00-11